GlaxoSmithKline (GSK) Consumer Healthcare has suspended operations temporarily at its factory in Nabha in Patiala district, to be effective from May 21, following disruptions created by its workforce.
“Due to certain disruptions created by the workforce/flash strike... the management of the company has decided to suspend operations temporarily at its factory located at Nabha with effect from the night of May 21,” the company said in a BSE filing on Monday.
The company added that it took the step “in the interest of safety and security of its employees and to protect the assets of the factory”.
The labourers of the company had been on a chain hunger strike since March 17 and had gone on complete strike on Saturday evening after the management suspended the labour union president, Mewa Singh, who was leading the protest against the company management, under the allegations of ‘misconduct’.
The meetings between the labour commissioner, the labour union and the company management had yielded no result and the issue was expected to be referred to the labour court.
Patiala assistant labour commissioner Jitendra Pal Singh had visited the plant on Sunday and said that he had not been consulted by the company before suspending Mewa Singh.
Last week, GSK had reported an 8.18% decline in its stand-alone net profit for the March quarter at Rs 180.7 crore. The company had posted a net profit of Rs 196.8 crore for the corresponding period a year ago. Net sales during the period under review was Rs 1,052.8 crore, down 9.63%, from Rs 1,165.1 crore in the same period last fiscal. For the full fiscal, GSK’s stand-alone net profit had risen 17.7% to Rs 686.9 crore as against Rs 583.6 crore in 2014-15. However, its net sales had declined 0.72% to Rs 4,106.6 crore in 2015-16, from Rs 4,136.4 crore a year ago.